Haematology · Oncology

NCCN-IPI for Diffuse Large B-Cell Lymphoma (Zhou) calculator

Enter the published formula inputs below to calculate and interpret this score.

Clinical inputs

Age

LDH

zhou stage iii iv

Major extranodal involvement (bone marrow, CNS, liver/GI, lung)

zhou ecog ≥ 2

Result

5 fields remaining

Anyone can run this calculator. Sign in to save, favourite, or send the result.

Ruqelo is AI and can make mistakes. Check important information.

Clinical inputs

Age
LDH
zhou stage iii iv
Major extranodal involvement (bone marrow, CNS, liver/GI, lung)
zhou ecog ≥ 2

Primary source

Zhou Z et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. DOI: 10.1182/blood-2013-09-524108. PMID: 24264230. Scope: NCCN-IPI points — age >40–≤60 (+1), >60–≤75 (+2), >75 (+3); LDH >1–≤3×ULN (+1), >3×ULN (+2); Ann Arbor III/IV (+1); major extranodal involvement (+1); ECOG ≥2 (+1); max 8. Groups: low 0–1, LI 2–3, HI 4–5, high 6–8. (2014)

View source